MX9305092A - Nuevas 4, 5-dihidro-4-oxo-pirrolo(1, 2-alquinoxalinas y sus correspondientes aza-analogos y procedimiento para su elaboracion. - Google Patents

Nuevas 4, 5-dihidro-4-oxo-pirrolo(1, 2-alquinoxalinas y sus correspondientes aza-analogos y procedimiento para su elaboracion.

Info

Publication number
MX9305092A
MX9305092A MX9305092A MX9305092A MX9305092A MX 9305092 A MX9305092 A MX 9305092A MX 9305092 A MX9305092 A MX 9305092A MX 9305092 A MX9305092 A MX 9305092A MX 9305092 A MX9305092 A MX 9305092A
Authority
MX
Mexico
Prior art keywords
oxo
aza
effects
alquinoxalinas
analogos
Prior art date
Application number
MX9305092A
Other languages
English (en)
Inventor
Bernhard Kutscher
Stefan Szelenyi
Ute Achterrath Tuckermann
Juergen Schmidt
Peter Metzenauer
Hans-Reinhold Dieter
Juergen Engel
Karl-Heinz Klingler
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of MX9305092A publication Critical patent/MX9305092A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Los nuevos compuestos de5, 5-hidro-4-oxo-pirrolo(1, 2-alquinoxalinas y sus correspondientes aza-analogos de acuerdo al invento son farmacológicamente efectivos en particular poseen efectos antialérgicos y antiasmáticos, efectos ansiolíticos, efectos hipotensivos (por ejemplo el bloqueo alfa2-selectivo), efectos vasodilatadore (inodilatadores) como así efecto inótropo positivo (inhid¡bición selectiva PDE-III-).
MX9305092A 1992-08-24 1993-08-23 Nuevas 4, 5-dihidro-4-oxo-pirrolo(1, 2-alquinoxalinas y sus correspondientes aza-analogos y procedimiento para su elaboracion. MX9305092A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4228095A DE4228095A1 (de) 1992-08-24 1992-08-24 Neue 4,5-Dihydro-4-oxo-pyrrolo[1,2-a]chinoxaline und entsprechende Aza-analoga und Verfahren zu deren Herstellung

Publications (1)

Publication Number Publication Date
MX9305092A true MX9305092A (es) 1994-02-28

Family

ID=6466304

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305092A MX9305092A (es) 1992-08-24 1993-08-23 Nuevas 4, 5-dihidro-4-oxo-pirrolo(1, 2-alquinoxalinas y sus correspondientes aza-analogos y procedimiento para su elaboracion.

Country Status (18)

Country Link
US (1) US5405847A (es)
EP (1) EP0584487A3 (es)
JP (1) JPH06184155A (es)
KR (1) KR940003957A (es)
CN (1) CN1088928A (es)
AU (1) AU661408B2 (es)
BR (1) BR9303456A (es)
CA (1) CA2104653A1 (es)
CZ (1) CZ170693A3 (es)
DE (1) DE4228095A1 (es)
FI (1) FI933705A (es)
HU (1) HUT70165A (es)
IL (1) IL106761A0 (es)
MX (1) MX9305092A (es)
NO (1) NO932998L (es)
PH (1) PH30110A (es)
SK (1) SK89693A3 (es)
ZA (1) ZA936169B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2704547B1 (fr) * 1993-04-30 1995-06-09 Adir Nouveaux composés pyrrolopyraziniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
DE19510965A1 (de) * 1995-03-24 1996-09-26 Asta Medica Ag Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung
US6465465B1 (en) 2000-03-14 2002-10-15 Arzneimittelwerk Dresden Gmbh Process for the treatment of erectile dysfunction and product therefor
DE10012373A1 (de) * 2000-03-14 2001-09-20 Dresden Arzneimittel Verwendung von Pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erektiler Dysfunktion
EP1312363A1 (en) * 2001-09-28 2003-05-21 Pfizer Products Inc. Methods of treatment and kits comprising a growth hormone secretagogue
US7550459B2 (en) 2001-12-28 2009-06-23 Acadia Pharmaceuticals, Inc. Tetrahydroquinoline analogues as muscarinic agonists
EP1461318B9 (en) 2001-12-28 2005-12-28 Acadia Pharmaceuticals Inc. Tetrahydroquinoline analogues as muscarinic agonists
US7342884B2 (en) * 2002-03-13 2008-03-11 Harmonic, Inc. Method and apparatus for one directional communications in bidirectional communications channel
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
EP2114948B1 (en) * 2006-12-28 2014-06-25 AbbVie Inc. Inhibitors of poly(adp-ribose)polymerase
MX2011007741A (es) 2009-01-23 2011-09-06 Takeda Pharmaceutical Inhibidores de poli(adenosina difosfato plaquetaria (adp)-ribosa) polimerasa poli adenosina difosfato plaquetaria ribosa (parp).
EP2459561A1 (en) 2009-07-30 2012-06-06 Takeda Pharmaceutical Company Limited Poly (adp-ribose) polymerase (parp) inhibitors
WO2011081915A2 (en) * 2009-12-15 2011-07-07 Cebix Inc. Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
EP2648754A4 (en) 2010-12-07 2016-02-24 Philadelphia Health & Educatio METHODS OF INHIBITING THE METASTASIS OF CANCER
WO2018204370A1 (en) 2017-05-02 2018-11-08 Drexel University Cx3cr1 small molecule antagonists, and methods using same
CN116075512A (zh) 2020-06-11 2023-05-05 Chdi基金会股份有限公司 用于对亨廷顿蛋白成像的杂环化合物和显像剂
CN114560862A (zh) * 2022-03-08 2022-05-31 山东龙辰药业有限公司 一种吡咯并[1,2-a]喹喔啉-4(5h)-酮及其衍生物的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576077A (en) * 1977-04-13 1980-10-01 Roussel Lab Ltd 4,5-dihydro-4-oxophyrrolo(1,2-)-quinoxaline-2-carboxylic acids and derivatives
GB2043637B (en) * 1979-02-09 1983-03-16 Roussel Lab Ltd Heterotricyclic derivatives
US4440929A (en) * 1981-07-16 1984-04-03 Usv Pharmaceutical Corporation Imidazoquinoxaline compounds
US4446323A (en) * 1983-05-23 1984-05-01 American Home Products Corporation Tetra- and hexa-hydropyrrolo(1,2-a)quinoxaline and azaquinoxaline derivatives
IL90315A0 (en) * 1988-06-01 1989-12-15 Ferrosan As Imidazoquinoxaline compounds,their preparation and pharmaceutical compositions containing them
DK626288D0 (da) * 1988-11-10 1988-11-10 Ferrosan As Kemisk proces til fremstilling af imidazoquinoxaliner og mellemprodukter til brug i processen
US5055465A (en) * 1989-05-31 1991-10-08 Berlex Laboratories, Inc. Imidazoquinoxalinones, their aza analogs and process for their preparation
US5306819A (en) * 1992-08-27 1994-04-26 Neurogen Corporation Certain aryl a cycloalkyl fused imidazopyrazinols; and new class of GABA brain receptor ligands

Also Published As

Publication number Publication date
FI933705A (fi) 1994-02-25
HUT70165A (en) 1995-09-28
CA2104653A1 (en) 1994-02-25
NO932998L (no) 1994-02-25
BR9303456A (pt) 1994-03-22
KR940003957A (ko) 1994-03-14
NO932998D0 (no) 1993-08-23
AU661408B2 (en) 1995-07-20
JPH06184155A (ja) 1994-07-05
SK89693A3 (en) 1994-03-09
IL106761A0 (en) 1993-12-08
EP0584487A2 (de) 1994-03-02
CN1088928A (zh) 1994-07-06
US5405847A (en) 1995-04-11
DE4228095A1 (de) 1994-03-03
CZ170693A3 (en) 1994-03-16
ZA936169B (en) 1994-03-17
FI933705A0 (fi) 1993-08-23
PH30110A (en) 1996-12-27
AU4483393A (en) 1994-03-03
HU9302397D0 (en) 1993-11-29
EP0584487A3 (en) 1994-07-06

Similar Documents

Publication Publication Date Title
MX9305092A (es) Nuevas 4, 5-dihidro-4-oxo-pirrolo(1, 2-alquinoxalinas y sus correspondientes aza-analogos y procedimiento para su elaboracion.
ES2116594T3 (es) Ansamicinas biciclicas y su uso como agentes antitumorales.
MX9304819A (es) Nuevos derivados de xantina y procedimiento para su preparacion.
SV1996000033A (es) Isotiazolonas
GT199900056A (es) Nuevas dihidropirimidinas
BRPI0110443B8 (pt) etapas processuais na produção de um composto de ecteinascidina
YU46738B (sh) Postupak za dobijanje benzodiazepina
ES2161231T3 (es) Compuestos heterociclicos como antagonistas de bradiquinina.
CO4650278A1 (es) Procedimiento y formas cristalinas de 2-metil-tieno-benzo- diacepina
ECSP034797A (es) DERIVADOS DIHIDRO-BENZO[b][1,4]DIAZEPIN-2-ONA COMO ANTAGONISTAS II MGLUR2
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
MX9400341A (es) Derivados de los acidos quinolon- y naftiridon-carboxilicos, procedimiento para su obtencion y agentes antibacterianos y aditivos para piensos que los contienen.
NO965516D0 (no) Sterolderivater anvendt til regulering av meiose
ES2111287T3 (es) Nueva forma cristalina de un analogo de la vitamina d.
MX9403915A (es) Derivados de n-alquiltio de pliamina como agentes radioprotectores.
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
ES2139669T3 (es) Nuevos derivados triciclicos de indan-2-mercaptoacetilamida 2-substituidos utiles como inhibidores de la encefalinasa.
ES2177811T3 (es) Uso de nitroflavonoides para el tratamiento de la ansiedad.
TR199801903A2 (xx) Sulfonamid ikameli ve bunlar� i�eren farmakolojik bile�imler.
IL150310A0 (en) Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
ES285586Y (es) Herramienta para el ajuste de vias de ferrocarril
SE9604582D0 (sv) Novel compounds
ES2104174T3 (es) Derivados de bencilamino, bencilamido y bencilimido ciclicos utilizados como agentes antipsicoticos.
MX9304152A (es) Inhibidores de enzimas.
ES2187783T3 (es) Derivados de indolina utiles como antagonistas del receptor 5-ht-2c.